{"id":4102,"date":"2024-03-13T12:13:05","date_gmt":"2024-03-13T12:13:05","guid":{"rendered":"https:\/\/www.everpharma.com\/?p=4102"},"modified":"2024-03-13T12:46:59","modified_gmt":"2024-03-13T12:46:59","slug":"ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu","status":"publish","type":"post","link":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/","title":{"rendered":"EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><strong>EVER Pharma, ein vollintegrierter Pharmaspezialist, hat die Zulassung von Testosteronundecanoat zur Behandlung von m\u00e4nnlichem Hypogonadismus in der Europ\u00e4ischen Union bekannt gegeben. Mit dieser Therapie, einer intramuskul\u00e4ren Injektion mit einzigartiger Depotformulierung, k\u00f6nnen die Symptome des Hypogonadismus bei M\u00e4nnern mit nachgewiesenem Testosteronmangel<sup>1 <\/sup>behandelt werden.<\/strong><\/p>\n\n\n\n<p>M\u00e4nnlicher Hypogonadismus ist eine Erkrankung, die durch niedrige Testosteronspiegel und eine Reihe damit verbundener Symptome gekennzeichnet ist und weltweit bis zu 10 % der M\u00e4nner und 40 % der M\u00e4nner im Alter von 45 Jahren betrifft<sup>2<\/sup>. Testosteronundecanoat ist ein langwirksames injizierbares Testosteron, das in der Androgenersatztherapie bei M\u00e4nnern eingesetzt wird. Die Therapie verbessert nachweislich Symptome wie verringerte Muskelmasse, M\u00fcdigkeit und verminderte Libido<sup>2<\/sup>.<\/p>\n\n\n\n<p>&#8222;M\u00e4nnlicher Hypogonadismus kann die Lebensqualit\u00e4t erheblich beeintr\u00e4chtigen, und es ist wichtig, dass wirksame Behandlungsm\u00f6glichkeiten zur Verf\u00fcgung stehen. Wir freuen uns, dass wir Patienten den Zugang zu dieser wichtigen Therapie erm\u00f6glichen k\u00f6nnen&#8220;, sagte Georges Kahwati, General Manager EVER Pharma.<\/p>\n\n\n\n<p>Die Zulassung von Testosteronundecanoat unterstreicht das Engagement von EVER Pharma f\u00fcr die weltweite Versorgung mit lebenswichtigen Medikamenten und die Kompetenz des Unternehmens in der Entwicklung und Herstellung komplexer Therapien, einschlie\u00dflich lang wirksamer Hormontherapien. Testosteronundecanoat EVER Pharma wird weltweit auf den Markt gebracht werden.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-1024x1024.png\" alt=\"\" class=\"wp-image-4100\" srcset=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-1024x1024.png 1024w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-300x300.png 300w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-150x150.png 150w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-768x768.png 768w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-1536x1536.png 1536w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-2048x2048.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:63px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-wpco-accordion accordion\" id=\"accordion-4102-1\">\n<div class=\"wp-block-wpco-accordion-body accordion-item\"><div class=\"accordion-header\" id=\"accordion-4102-1-item-1-heading\"><button class=\"accordion-button has-theme-gray-background-color has-theme-copy-color\" data-bs-toggle=\"collapse\" data-bs-target=\"#accordion-4102-1-item-1-body\">Quellen<\/button><\/div><div class=\"accordion-collapse collapse\" id=\"accordion-4102-1-item-1-body\" aria-labelledby=\"accordion-4102-1-item-1-heading\" data-bs-parent=\"#accordion-4102-1\"><div class=\"accordion-body has-theme-light-gray-background-color has-theme-copy-color\">\n<p><sup>1<\/sup>Testosteronundecanoat EVER&nbsp;Pharma ist angezeigt f\u00fcr die Testosteronersatztherapie bei m\u00e4nnlichem Hypogonadismus, wenn der Testosteronmangel klinisch und labormedizinisch best\u00e4tigt wurde.<br><sup>2<\/sup>Campbell K., Muthigi A., Ghomeshi A., Schuppe K., Sandler M. D., &amp; Ramasamy R. (2023). Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights. Drug Healthc Patient Safety, 15, 73-84.<\/p>\n\n\n\n<p><\/p>\n<\/div><\/div><\/div>\n<\/div>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>EVER Pharma, ein vollintegrierter Pharmaspezialist, hat die Zulassung von Testosteronundecanoat zur Behandlung von m\u00e4nnlichem Hypogonadismus in der Europ\u00e4ischen Union bekannt gegeben. Mit dieser Therapie, einer intramuskul\u00e4ren Injektion mit einzigartiger Depotformulierung, k\u00f6nnen die Symptome des Hypogonadismus bei M\u00e4nnern mit nachgewiesenem Testosteronmangel1 behandelt werden. M\u00e4nnlicher Hypogonadismus ist eine Erkrankung, die durch niedrige Testosteronspiegel und eine Reihe damit &hellip; <a href=\"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/\">Weiterlesen<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4102","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU - EVER Pharma<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU - EVER Pharma\" \/>\n<meta property=\"og:description\" content=\"EVER Pharma, ein vollintegrierter Pharmaspezialist, hat die Zulassung von Testosteronundecanoat zur Behandlung von m\u00e4nnlichem Hypogonadismus in der Europ\u00e4ischen Union bekannt gegeben. Mit dieser Therapie, einer intramuskul\u00e4ren Injektion mit einzigartiger Depotformulierung, k\u00f6nnen die Symptome des Hypogonadismus bei M\u00e4nnern mit nachgewiesenem Testosteronmangel1 behandelt werden. M\u00e4nnlicher Hypogonadismus ist eine Erkrankung, die durch niedrige Testosteronspiegel und eine Reihe damit &hellip; Weiterlesen\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/\" \/>\n<meta property=\"og:site_name\" content=\"EVER Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-13T12:13:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-13T12:46:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-1024x1024.png\" \/>\n<meta name=\"author\" content=\"Magdalena\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Magdalena\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/\"},\"author\":{\"name\":\"Magdalena\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#\\\/schema\\\/person\\\/fddfefac0cbd5adf0a20c4e09a52cd65\"},\"headline\":\"EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU\",\"datePublished\":\"2024-03-13T12:13:05+00:00\",\"dateModified\":\"2024-03-13T12:46:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/\"},\"wordCount\":269,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/TUD-1-1024x1024.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/\",\"name\":\"EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU - EVER Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/TUD-1-1024x1024.png\",\"datePublished\":\"2024-03-13T12:13:05+00:00\",\"dateModified\":\"2024-03-13T12:46:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/TUD-1-1024x1024.png\",\"contentUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/TUD-1-1024x1024.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/\",\"name\":\"EVER Pharma\",\"description\":\"Dedicated to health.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":[\"Organization\",\"MedicalOrganization\"],\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#organization\",\"name\":\"EVER Pharma\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/ever-pharma-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/ever-pharma-logo.png\",\"width\":240,\"height\":67,\"caption\":\"EVER Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"legalName\":\"EVER Neuro Pharma GmbH\",\"foundingDate\":\"1934-01-01\",\"description\":\"EVER Pharma is a fully integrated specialty pharmaceuticals company specializing in the research, development, and production of sterile injectables and specialty generics for neurology, oncology, intensive care, and hormone therapeutics worldwide.\",\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"Oberburgau 3\",\"addressLocality\":\"Unterach am Attersee\",\"addressRegion\":\"Ober\u00f6sterreich\",\"postalCode\":\"4866\",\"addressCountry\":\"AT\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"contactType\":\"customer service\",\"telephone\":\"+43 7665 20555 0\",\"email\":\"office@everpharma.com\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ever-pharma\\\/\",\"https:\\\/\\\/www.wikidata.org\\\/wiki\\\/Q30268961\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#\\\/schema\\\/person\\\/fddfefac0cbd5adf0a20c4e09a52cd65\",\"name\":\"Magdalena\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g\",\"caption\":\"Magdalena\"},\"sameAs\":[\"https:\\\/\\\/everpharma.com\"],\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/author\\\/mschmitzberger\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU - EVER Pharma","robots":{"index":"noindex","follow":"follow"},"og_locale":"de_DE","og_type":"article","og_title":"EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU - EVER Pharma","og_description":"EVER Pharma, ein vollintegrierter Pharmaspezialist, hat die Zulassung von Testosteronundecanoat zur Behandlung von m\u00e4nnlichem Hypogonadismus in der Europ\u00e4ischen Union bekannt gegeben. Mit dieser Therapie, einer intramuskul\u00e4ren Injektion mit einzigartiger Depotformulierung, k\u00f6nnen die Symptome des Hypogonadismus bei M\u00e4nnern mit nachgewiesenem Testosteronmangel1 behandelt werden. M\u00e4nnlicher Hypogonadismus ist eine Erkrankung, die durch niedrige Testosteronspiegel und eine Reihe damit &hellip; Weiterlesen","og_url":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/","og_site_name":"EVER Pharma","article_published_time":"2024-03-13T12:13:05+00:00","article_modified_time":"2024-03-13T12:46:59+00:00","og_image":[{"url":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-1024x1024.png","type":"","width":"","height":""}],"author":"Magdalena","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Magdalena","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/#article","isPartOf":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/"},"author":{"name":"Magdalena","@id":"https:\/\/www.everpharma.com\/de\/#\/schema\/person\/fddfefac0cbd5adf0a20c4e09a52cd65"},"headline":"EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU","datePublished":"2024-03-13T12:13:05+00:00","dateModified":"2024-03-13T12:46:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/"},"wordCount":269,"commentCount":0,"publisher":{"@id":"https:\/\/www.everpharma.com\/de\/#organization"},"image":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/#primaryimage"},"thumbnailUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-1024x1024.png","articleSection":["News"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/","url":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/","name":"EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU - EVER Pharma","isPartOf":{"@id":"https:\/\/www.everpharma.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/#primaryimage"},"image":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/#primaryimage"},"thumbnailUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-1024x1024.png","datePublished":"2024-03-13T12:13:05+00:00","dateModified":"2024-03-13T12:46:59+00:00","breadcrumb":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/#primaryimage","url":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-1024x1024.png","contentUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/03\/TUD-1-1024x1024.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-zulassung-fuer-testosteronundecanoat-in-der-eu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.everpharma.com\/de\/"},{"@type":"ListItem","position":2,"name":"EVER Pharma erh\u00e4lt Zulassung f\u00fcr Testosteronundecanoat in der EU"}]},{"@type":"WebSite","@id":"https:\/\/www.everpharma.com\/de\/#website","url":"https:\/\/www.everpharma.com\/de\/","name":"EVER Pharma","description":"Dedicated to health.","publisher":{"@id":"https:\/\/www.everpharma.com\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.everpharma.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":["Organization","MedicalOrganization"],"@id":"https:\/\/www.everpharma.com\/de\/#organization","name":"EVER Pharma","url":"https:\/\/www.everpharma.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.everpharma.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2022\/07\/ever-pharma-logo.png","contentUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2022\/07\/ever-pharma-logo.png","width":240,"height":67,"caption":"EVER Pharma"},"image":{"@id":"https:\/\/www.everpharma.com\/de\/#\/schema\/logo\/image\/"},"legalName":"EVER Neuro Pharma GmbH","foundingDate":"1934-01-01","description":"EVER Pharma is a fully integrated specialty pharmaceuticals company specializing in the research, development, and production of sterile injectables and specialty generics for neurology, oncology, intensive care, and hormone therapeutics worldwide.","address":{"@type":"PostalAddress","streetAddress":"Oberburgau 3","addressLocality":"Unterach am Attersee","addressRegion":"Ober\u00f6sterreich","postalCode":"4866","addressCountry":"AT"},"contactPoint":{"@type":"ContactPoint","contactType":"customer service","telephone":"+43 7665 20555 0","email":"office@everpharma.com"},"sameAs":["https:\/\/www.linkedin.com\/company\/ever-pharma\/","https:\/\/www.wikidata.org\/wiki\/Q30268961"]},{"@type":"Person","@id":"https:\/\/www.everpharma.com\/de\/#\/schema\/person\/fddfefac0cbd5adf0a20c4e09a52cd65","name":"Magdalena","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g","caption":"Magdalena"},"sameAs":["https:\/\/everpharma.com"],"url":"https:\/\/www.everpharma.com\/de\/author\/mschmitzberger\/"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/posts\/4102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/comments?post=4102"}],"version-history":[{"count":11,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/posts\/4102\/revisions"}],"predecessor-version":[{"id":4186,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/posts\/4102\/revisions\/4186"}],"wp:attachment":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/media?parent=4102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/categories?post=4102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/tags?post=4102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}